Stay updated on ADXS11-001 in High Risk Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page.

Latest updates to the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status indicates the trial has ceased and is no longer seeking participants. New/updated sections include How to Read a Study Record, Common Questions, How to Join a Study, and an updated revision stamp to v3.6.0, with a formatting change from Intervention / Treatment to Intervention/Treatment.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now shows revision v3.5.5, replacing v3.5.4. It reflects a software update to the site rather than any change to the study details or eligibility information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 removed, indicating a version update on the page. This is a technical change reflecting an update to the page's revision label rather than any adjustment to study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe study site location was updated from Taoyuan District, Taiwan, 3331 to Taoyuan, Taiwan, 3331 to clarify the municipality associated with the site.SummaryDifference0.0%

- Check52 days agoChange DetectedThe site’s displayed location text for Chile is adjusted by simplifying/changing the regional naming (“Región de la Araucanía” to “Araucania”) for a specific location entry. The page also updates its displayed software/revision version from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision updated to v3.5.0, and the previous Revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to ADXS11-001 in High Risk Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS11-001 in High Risk Cervical Cancer Clinical Trial page.